What Is Multi-Microbial Activation Syndrome (MMAS)?

Multi-Microbial Activation Syndrome (MMAS) is a complex condition in which multiple latent microbes in the body activate simultaneously, overwhelming the immune system and causing treatment-resistant illnesses. Unlike single-pathogen conditions, MMAS involves a combination of bacteria, viruses, fungi, and other microbes that work together to disrupt the body’s natural balance, leading to chronic symptoms.

MMAS can underlie or exacerbate other chronic conditions such as Lyme disease, autoimmune disorders, and fibromyalgia, making it a significant barrier to recovery.

Patients with MMAS often experience:

Persistent fatigue
Widespread inflammation
Chronic pain
Neurological symptoms
Gastrointestinal issues

Get Treatment for MMAS

INPT for MMAS

Why Traditional Treatments Fall Short

Conventional treatments for microbial infections, such as antibiotics and antifungals, often fail to address MMAS. Here’s why:

Microbial Resistance:

Microbes adapt quickly, making traditional treatments less effective over time.

Broad-Spectrum Damage:

Antibiotics and other treatments can harm beneficial microbes in the microbiome, worsening overall health.

Inadequate Targeting:

Multi-pathogen conditions require a more precise approach that current pharmaceutical solutions lack.

The result? Patients continue to struggle with unresolved symptoms, while their health and microbiome suffer from collateral damage caused by aggressive treatments.

Biologix Center’s Unique Approach to MMAS

At Biologix Center, we take a revolutionary approach to treating MMAS by addressing the root cause: the overactivation of multiple pathogens. Our treatment strategy works in harmony with the body’s natural systems to restore balance and promote healing.

Induced Native Phage Therapy (INPT)

Our signature treatment, Induced Native Phage Therapy (INPT), uses electromagnetic signatures stored in sterile, preservative-free liquids to activate naturally occurring viruses—called phages—already present in the body. These phages target and eliminate harmful microbes while preserving beneficial bacteria in the microbiome.

Precise Targeting: INPT can address over 100 types of pathogens simultaneously, including bacteria, fungi, and viruses.
Safe and Non-Disruptive: Unlike antibiotics, INPT leaves your beneficial microbes untouched, supporting long-term microbiome health.
Comprehensive Action: INPT also targets microbial toxins like endotoxins and biofilms, enhancing recovery.

Bioregulatory Medicine

In addition to INPT, we use a combination of bioregulatory therapies tailored to each patient’s unique needs. These therapies work synergistically to restore the body’s natural regulatory systems, enabling long-lasting health improvements.

Science Supporting Our Approach

Clinical studies and real-world evidence demonstrate the effectiveness of INPT and bioregulatory medicine in addressing MMAS:

Up to 92% of patients treated with INPT tested negative for targeted pathogens after treatment.
INPT minimizes adverse reactions, including the Jarisch-Herxheimer reaction, often seen in aggressive microbial treatments.
Scientific studies confirm that phages can dissolve biofilms, which shield pathogens from conventional treatments.

Explore the Research

Who Can Benefit from MMAS Treatment?

Biologix Center’s approach to MMAS is ideal for:

Patients with unresolved chronic conditions, such as Lyme disease, autoimmune disorders, or fibromyalgia.
Individuals experiencing persistent symptoms despite conventional treatments.
Those seeking natural, non-invasive solutions that work with their body’s innate healing capabilities.

Schedule an Appointment about MMAS